All practice questions

771 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

During morning rounds in the medical intensive care unit, a $24$ -year-old man is evaluated. He was admitted $18$ hours ago with severe diabetic ketoacidosis. He has received aggressive fluid resuscitation and a continuous intravenous regular insulin infusion. Currently, he is asymptomatic, alert, and requesting breakfast. His most recent basic metabolic panel demonstrates a serum bicarbonate of $21\text{ mEq/L}$ and an anion gap of $10\text{ mEq/L}$ . Venous pH is $7.34$ . Point-of-care blood glucose is $175\text{ mg/dL}$ . The care team decides it is time to transition him to a maintenance regimen of subcutaneous glargine and lispro insulin. Arrange the following steps in the most appropriate chronological sequence to safely accomplish this therapeutic transition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient off an insulin infusion is to first administer the subcutaneous insulin, continue the intravenous infusion for a 1- to 2-hour overlap, then discontinue the intravenous infusion, and finally resume standard pre-meal blood glucose monitoring.

The clinically correct and safe sequence for resolving diabetic ketoacidosis involves waiting until resolution criteria are met (anion gap

< 12\text{ mEq/L}

, pH

> 7.3

, tolerating PO), which this patient has achieved. At this point, subcutaneous insulin is administered. Because intravenous insulin clears the body within minutes and subcutaneous insulin takes

1

2

hours to onset, a mandatory overlap of

1

2

hours is required. After this overlap, the intravenous infusion is stopped, and standard routine blood glucose monitoring continues.

Step-by-Step Solution

Administer the scheduled dose of subcutaneous basal and rapid-acting insulin.

The patient receives the first dose of their home subcutaneous insulin regimen while still on the intravenous infusion.

Subcutaneous insulin requires time for absorption and onset of action, making it the necessary first step in the transition protocol.

Maintain the continuous intravenous regular insulin infusion for

1

2

additional hours.

Intravenous and subcutaneous insulin delivery overlap for a critical safety window.

Intravenous insulin has a half-life of only a few minutes. Without an overlap period, insulin levels will drop to zero before the subcutaneous insulin begins working, risking a rapid relapse into ketoacidosis.

Discontinue the continuous intravenous regular insulin infusion.

The intravenous line delivering insulin is stopped.

Once the subcutaneous insulin has reached sufficient systemic levels (after the 1-2 hour overlap), the intravenous infusion is no longer needed and can be safely stopped.

Assess the point-of-care blood glucose prior to the patient's next meal.

Routine glucose monitoring is established.

With the acute crisis resolved and the patient on a standard regimen, monitoring safely transitions to standard pre-prandial and bedtime checks.

Key Concept

Patients recovering from diabetic ketoacidosis require a 1- to 2-hour overlap between the administration of subcutaneous insulin and the discontinuation of the intravenous insulin infusion to prevent rebound ketoacidosis.

Estimated Time:1m 30s

Question 542Question →

A 22-year-old man with type 1 diabetes mellitus is managed in the intensive care unit for diabetic ketoacidosis (DKA). He has been receiving a continuous intravenous regular insulin infusion, appropriate intravenous fluids, and potassium supplementation for the past $14$ hours. The most recent basic metabolic panel reveals a blood glucose of $185$ mg/dL, a serum bicarbonate of $19$ mEq/L, and a calculated anion gap of $10$ mEq/L. The patient is awake, alert, and states he is hungry. The physician decides to transition the patient from intravenous to subcutaneous insulin therapy. Arrange the following steps in the most appropriate chronological order to safely accomplish this therapeutic transition and ongoing monitoring.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient from intravenous to subcutaneous insulin after DKA resolution is: 1) Document DKA resolution and oral tolerance, 2) Administer subcutaneous insulin, 3) Continue IV insulin for a 1-2 hour overlap, 4) Stop IV insulin, 5) Begin routine pre-meal and bedtime blood glucose monitoring.

The correct sequence follows guideline-directed de-escalation of DKA management. First, criteria for resolution must be met (glucose <

200

mg/dL, bicarbonate \geq

18

mEq/L, and calculated anion gap \leq

12

mEq/L) and the patient must tolerate oral intake. Next, subcutaneous insulin (both basal and prandial) is administered. Crucially, the intravenous regular insulin infusion must be continued for

1

2

hours after the subcutaneous injection. This overlap is required because intravenous insulin has a half-life of less than

10

minutes, whereas subcutaneous insulin takes

1

2

hours to achieve significant systemic absorption. Stopping the IV infusion prematurely leads to a lapse in circulating insulin and rebound ketoacidosis. Once the overlap period concludes, the IV infusion is stopped, and the patient is placed on routine blood glucose monitoring to evaluate the new regimen.

Step-by-Step Solution

Confirm clinical and biochemical resolution

Anion gap is closed (\leq

12

mEq/L) and patient can eat.

Ensures the patient is physiologically ready for therapeutic de-escalation.

Administer subcutaneous insulin

Patient receives basal and prandial SQ dose.

Provides the new source of insulin before the old one is removed.

Overlap IV and SQ insulin

IV infusion runs concurrently for

1

2

hours post-SQ injection.

Prevents insulin deficiency and rebound DKA while SQ insulin absorbs.

Stop IV insulin

Patient is solely on SQ insulin.

Completes the transition once SQ insulin is fully active.

Start routine monitoring

Point-of-care glucose checks are scheduled before meals and at bedtime.

Allows evaluation of the new SQ regimen's efficacy and ensures stability.

Key Concept

Multi-step therapeutic de-escalation and monitoring protocol for Diabetic Ketoacidosis (DKA)

Question 543Question →

A 48-year-old man is brought to the emergency department via ambulance due to a prolonged seizure. His wife reports that he abruptly lost consciousness and began experiencing generalized shaking while eating breakfast. The paramedics arrived 10 minutes after the onset of the episode and noted continuous, generalized tonic-clonic motor activity. En route to the hospital, his convulsions did not cease. On arrival in the emergency bay, the patient remains unresponsive with active generalized tonic-clonic movements. His estimated weight is 80 kg (176 lb). Vital signs show a blood pressure of 168/94 mmHg, heart rate of 136/min, and oxygen saturation of 92% on a non-rebreather mask. Point-of-care blood glucose is 102 mg/dL. He has no established intravenous access.

Arrange the following pharmacologic interventions in the correct sequential order for the evidence-based management of this patient's emergency, from the immediate initial step to the therapy reserved for super-refractory disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing status epilepticus in this scenario is: 1) Administer intramuscular midazolam, 2) Establish intravenous access and administer intravenous fosphenytoin, 3) Perform endotracheal intubation and initiate a continuous propofol infusion, 4) Initiate a continuous pentobarbital infusion with continuous electroencephalogram monitoring.

The management of status epilepticus follows a strict, time-dependent treatment algorithm. In the initial stabilization phase (0-5 minutes), administering a first-line benzodiazepine is critical. Because this patient lacks IV access, intramuscular (IM) midazolam is the evidence-based first choice; attempting IV access during active convulsions delays life-saving therapy. Once the initial abortive agent is given, IV access is established to administer a second-line non-benzodiazepine antiseizure medication (e.g., IV fosphenytoin, valproate, or levetiracetam) at the 20-minute mark to treat established status. If clinical or electrographic seizures persist beyond 40 minutes despite these interventions, the patient has entered refractory status epilepticus. This condition requires endotracheal intubation for airway protection and the initiation of a continuous anesthetic infusion, such as propofol or midazolam. Finally, if the patient continues to seize despite a continuous anesthetic infusion for over 24 hours (super-refractory status epilepticus), the intervention of last resort is inducing a deep barbiturate coma (e.g., pentobarbital or thiopental infusion) guided by continuous electroencephalogram (EEG) monitoring to achieve burst suppression.

Step-by-Step Solution

Identify the clinical emergency and assess logistical constraints.

The patient is in generalized convulsive status epilepticus (seizure duration >5 minutes) and currently lacks intravenous access.

Immediate pharmacologic termination of the seizure is required to prevent irreversible neuronal injury, but the route of administration is dictated by the lack of an IV line.

Select the appropriate first-line abortive agent.

Intramuscular midazolam is chosen as the initial intervention.

Current guidelines strictly recommend IM midazolam as the first-line agent when IV access is not immediately available, as it has rapid absorption and avoids the delay of attempting IV placement in a convulsing patient.

Determine the necessary second-line maintenance therapy.

Intravenous fosphenytoin is administered once IV access is secured.

A long-acting, non-benzodiazepine antiseizure medication is required at the 20-minute mark to treat established status epilepticus and prevent seizure recurrence.

Plan for the management of refractory status epilepticus.

Endotracheal intubation and a continuous propofol infusion are prioritized next.

Failure of first- and second-line agents defines refractory status, which necessitates mechanical ventilation and continuous general anesthesia to suppress cortical activity.

Plan for the management of super-refractory status epilepticus.

Continuous pentobarbital infusion guided by EEG is the final step.

Failure of a continuous anesthetic infusion requires escalation to a deep barbiturate coma with burst suppression monitoring, which is the therapy of last resort due to high morbidity.

Key Concept

The protocolized, sequential escalation of pharmacotherapy in status epilepticus based on time elapsed and response to prior treatments.

Question 544Question →

A 28-year-old man with type 1 diabetes mellitus is receiving care in the intensive care unit for severe diabetic ketoacidosis. He is currently being managed with intravenous fluid resuscitation and a continuous intravenous regular insulin infusion. Arrange the following clinical milestones and monitoring-based interventions in the correct chronological sequence required for a safe transition to maintenance subcutaneous therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with monitoring blood glucose until it reaches 200 mg/dL, immediately adding dextrose to the IV fluids, continuing to monitor until the anion gap closes, administering subcutaneous insulin, and finally discontinuing the IV insulin infusion two hours later.

The standard protocol for managing diabetic ketoacidosis (DKA) requires rigorous sequential monitoring and treatment modification. Initially, IV fluids and an insulin infusion are started. Because glucose normalizes faster than the ketoacidosis resolves, when the blood glucose falls to 200 mg/dL, 5% dextrose must be added to the IV fluids. This prevents hypoglycemia and allows the insulin infusion to continue suppressing lipolysis and ketogenesis. The physician must then monitor serial basic metabolic panels until the anion gap closes (≤ 12 mEq/L), which signals the resolution of DKA. Once resolved, the transition to subcutaneous insulin is initiated by administering a long-acting basal dose. Finally, because subcutaneous insulin takes 1 to 2 hours to achieve therapeutic systemic absorption, the IV insulin infusion must be maintained for an overlapping 2-hour period before being discontinued to prevent a relapse of DKA.

Step-by-Step Solution

Monitor capillary blood glucose hourly until it reaches the 200 mg/dL threshold.

Identifies the point where the patient is at risk for hypoglycemia if pure saline is continued.

Blood glucose typically normalizes much faster than the metabolic acidosis resolves.

Add 5% dextrose to the intravenous fluid regimen.

Maintains blood glucose levels in a safe range (150-200 mg/dL).

Allows the continuous insulin infusion to be maintained at a rate sufficient to clear ketones without inducing iatrogenic hypoglycemia.

Monitor serial chemistry panels every 2 to 4 hours to assess the anion gap.

Confirms the closure of the anion gap (typically ≤ 12 mEq/L) and normalization of bicarbonate.

Closure of the anion gap is the definitive marker that diabetic ketoacidosis has resolved and continuous IV insulin is no longer strictly required for ketone suppression.

Administer the first dose of subcutaneous basal insulin.

Begins the transition to long-term maintenance therapy.

Subcutaneous insulin must be given once the acidosis is resolved and the patient is preparing to resume an oral diet.

Maintain the IV insulin infusion for an additional 2 hours before discontinuing it.

Provides an insulin overlap.

Subcutaneous insulin has a delayed onset of action. The overlap prevents a window of insulin deficiency and subsequent rebound ketoacidosis.

Key Concept

Monitoring and Sequencing the Transition off Intravenous Insulin in Diabetic Ketoacidosis

Question 545Question →

A 42-year-old woman is brought to the emergency department by her husband due to severe confusion, agitation, and recurrent vomiting for the past 24 hours. She was diagnosed with Graves disease two years ago but has not taken any medications for the past six months. Temperature is 39.8°C (103.6°F), blood pressure is 155/65 mm Hg, pulse is 152/min and irregular, and respirations are 26/min. Physical examination shows a confused, diaphoretic woman with a diffusely enlarged, non-tender thyroid gland, bilateral proptosis, and severe fine resting tremor. ECG shows atrial fibrillation with rapid ventricular response. A diagnosis of thyroid storm is made, and the patient is admitted to the intensive care unit.

Arrange the following pharmacologic interventions in the most appropriate chronological order of administration for this patient's comprehensive management, from initial acute stabilization to long-term definitive therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Intravenous propranolol, followed by Oral propylthiouracil (PTU), then Oral potassium iodide, and finally Radioactive iodine ablation.

The management of thyroid storm requires a strict sequence of pharmacologic blockade targeting different pathophysiological steps. First, peripheral adrenergic effects are controlled immediately with a beta-blocker (propranolol). Second, new hormone synthesis is blocked with a thioamide (PTU). Third, the release of preformed hormone is blocked with iodine (potassium iodide), which must be given at least 1 hour after the thioamide to prevent it from being used as a substrate for new hormone synthesis. Finally, after the acute crisis resolves and the patient is euthyroid (often weeks later), definitive therapy with radioactive iodine ablation or surgery is performed.

Step-by-Step Solution

Administer intravenous propranolol.

Heart rate decreases and adrenergic symptoms are controlled.

Immediate life-threatening cardiovascular and sympathetic manifestations must be managed first to prevent hemodynamic collapse.

Administer oral propylthiouracil (PTU).

Thyroid hormone synthesis is halted at the follicular level.

PTU blocks thyroid peroxidase and prevents synthesis of new hormone. It also blocks peripheral T4 to T3 conversion. It must be in the system before introducing exogenous iodine.

Administer oral potassium iodide.

Release of preformed thyroid hormone from the gland is blocked.

Must be given at least 1 hour after PTU to prevent the iodine from being utilized as a substrate for new hormone synthesis, exploiting the Wolff-Chaikoff effect safely.

Perform radioactive iodine ablation.

Definitive destruction of the hyperactive thyroid tissue is achieved.

Only safe to perform on an outpatient basis weeks later once the patient is euthyroid, to prevent radiation-induced thyroiditis from triggering another thyrotoxic crisis.

Key Concept

Chronological pharmacologic management of thyroid storm

Question 546Question →

A 58-year-old woman is evaluated in the intensive care unit for a rapidly declining platelet count. She was admitted 6 days ago for severe pneumonia and started on broad-spectrum antibiotics and prophylactic subcutaneous unfractionated heparin. Her platelet count on admission was $250,000/\mu L$ and is now $55,000/\mu L$ . She has no active bleeding, but a lower extremity ultrasound reveals a new deep vein thrombosis in the right femoral vein. The clinical team diagnoses highly probable heparin-induced thrombocytopenia (HIT) with thrombosis. Arrange the following steps regarding the ongoing monitoring and transition of pharmacotherapy for this patient in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediately stopping all heparin products, followed by initiating a non-heparin parenteral anticoagulant, monitoring platelets until they recover to at least

150,000/\mu L

, initiating warfarin overlap, and finally discontinuing the parenteral anticoagulant once the INR is therapeutic for 48 hours.

The management of Heparin-Induced Thrombocytopenia (HIT) follows a strict, highly tested sequence. First, the inciting agent (all heparin products) must be immediately withdrawn to stop the underlying pathophysiology. Second, because HIT is profoundly prothrombotic (as evidenced by this patient's new deep vein thrombosis), immediate alternative parenteral anticoagulation (e.g., argatroban, bivalirudin, or fondaparinux) is required. Third, the clinician must monitor the patient's platelet count daily; this serves as the primary metric for treatment evaluation. Fourth, only after the platelet count has recovered to normal levels (

\ge 150,000/\mu L

) is it safe to initiate warfarin. Finally, standard bridging rules apply: the parenteral agent must be continued for at least 5 days AND until the INR is therapeutic (2.0-3.0) for at least 48 hours before it can be safely discontinued.

Step-by-Step Solution

Stop all heparin exposure.

Halts the formation of heparin-PF4-antibody complexes.

Continued exposure to even minimal amounts of heparin (like flushes) perpetuates the prothrombotic state.

Start a non-heparin parenteral anticoagulant (e.g., argatroban).

Provides immediate anticoagulation to treat the existing deep vein thrombosis.

Patients with HIT have an extremely high risk of progressive or new thrombosis, necessitating immediate alternative anticoagulation.

Monitor platelet count daily.

Identifies the resolution of the acute HIT phase once platelets reach

\ge 150,000/\mu L

Platelet recovery indicates that the profound hypercoagulable state is subsiding, marking the safe window for transition to oral therapy.

Initiate oral warfarin therapy while continuing the parenteral anticoagulant.

Begins the transition to long-term outpatient anticoagulation.

Warfarin must be delayed until platelet recovery to avoid the rapid depletion of Protein C, which can paradoxically worsen thrombosis.

Discontinue the parenteral anticoagulant after 48 hours of a therapeutic INR.

Completes the transition to monotherapy with warfarin.

Bridging ensures that warfarin has achieved its full antithrombotic effect (depletion of prothrombin/Factor II) before the rapid-acting agent is removed.

Key Concept

Monitoring and Treatment Evaluation in Heparin-Induced Thrombocytopenia (HIT)

Estimated Time:1m 30s

Question 547Question →

A 72-year-old man with a 6-year history of Parkinson disease is brought to the neurology clinic by his wife due to new-onset visual hallucinations over the past two weeks. He reports seeing unfamiliar people standing in his living room, which is causing him significant distress. His motor symptoms (tremor and bradykinesia) have been well-controlled recently. His current daily medication regimen includes carbidopa-levodopa, pramipexole, amantadine, and trihexyphenidyl. Vital signs are within normal limits. Neurologic examination shows mild resting tremor and rigidity, unchanged from his previous visit. Laboratory studies, including a urinalysis and basic metabolic panel, are unremarkable.

According to the standard step-wise approach for managing Parkinson disease-related psychosis, arrange the following pharmacologic modifications in the correct sequential order (from the first step to the final step).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order is to first discontinue trihexyphenidyl, then discontinue amantadine, then discontinue pramipexole, and finally initiate quetiapine if symptoms persist.

The management of Parkinson disease psychosis involves a step-wise approach to minimize medication-induced delirium while attempting to preserve motor function. The first step is always to rule out general medical conditions (e.g., infections). Once ruled out, a sequential reduction of adjunctive Parkinson medications is performed in reverse order of their motor efficacy and forward order of their side effect profile. Anticholinergics (trihexyphenidyl) are the most deliriogenic and provide the least motor benefit, making them the first to be discontinued. If symptoms persist, amantadine is discontinued next. This is followed by MAO-B inhibitors (if present) and then dopamine agonists (pramipexole). Only if psychosis persists despite the withdrawal of these adjunctive therapies (or if severe motor deterioration prevents their withdrawal) should an atypical antipsychotic with low extrapyramidal risk, such as quetiapine or pimavanserin, be initiated.

Step-by-Step Solution

Identify the primary clinical problem

The patient is experiencing new-onset visual hallucinations (psychosis) induced by Parkinson disease medications, with secondary causes (e.g., infection, metabolic derangements) already ruled out.

Visual hallucinations are a common adverse effect of dopaminergic and anticholinergic therapies in advanced Parkinson disease and must be managed systematically.

Determine the first step in the medication taper protocol

Discontinue the anticholinergic agent (trihexyphenidyl).

Anticholinergics carry the highest risk for cognitive impairment and hallucinations with the least motor benefit, making them the absolute first target for discontinuation.

Determine the next sequential medications to withdraw if symptoms persist

Discontinue amantadine, followed by the dopamine agonist (pramipexole).

Amantadine has high neuropsychiatric toxicity and should be removed next. Dopamine agonists are tapered after amantadine because they provide greater motor control, even though they frequently trigger psychosis.

Determine the final intervention for refractory psychosis

Initiate an atypical antipsychotic (quetiapine).

If psychosis persists despite discontinuing adjunctive therapies, a low-potency atypical antipsychotic without significant D2 antagonism is added to avoid worsening motor symptoms.

Key Concept

The step-wise pharmacologic management of Parkinson disease psychosis involves sequentially discontinuing adjunctive medications in reverse order of motor efficacy (anticholinergics, then amantadine, then MAO-B inhibitors, then dopamine agonists) before initiating an atypical antipsychotic.

Question 548Question →

A 32-year-old man is brought to the emergency department by ambulance due to a generalized tonic-clonic seizure. His partner reports that the abnormal movements started 20 minutes ago and have been continuous without any periods of responsiveness. He has no known medical history. Initial vital signs include a blood pressure of 145/85 mm Hg, heart rate of 118/min, and oxygen saturation of 94% on room air. No medications were administered en route. Two large-bore peripheral intravenous lines are immediately established in the resuscitation bay. Arrange the following pharmacologic interventions in the evidence-based sequence for the escalating management of status epilepticus, from initial abortive therapy to the treatment of super-refractory cases.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the pharmacologic escalation in status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous fosphenytoin, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital infusion.

The American Epilepsy Society treatment algorithm for status epilepticus involves a strict step-wise escalation. Phase 1 (0-10 minutes) requires a rapid-acting benzodiazepine such as intravenous lorazepam to abort the seizure. Phase 2 (10-30 minutes) utilizes a non-anesthetic antiepileptic drug such as intravenous fosphenytoin to achieve sustained control and prevent recurrence. Phase 3 (30-60 minutes) addresses refractory status epilepticus using continuous infusions of general anesthetics like propofol or midazolam. Finally, Phase 4 addresses super-refractory status epilepticus (seizures persisting >24 hours despite anesthetics) with deep barbiturate coma using agents like pentobarbital.

Step-by-Step Solution

Identify the patient's presentation as generalized convulsive status epilepticus.

The patient has had continuous seizures for 20 minutes, which meets the criteria for status epilepticus (continuous seizure >5 minutes), requiring immediate protocolized pharmacological escalation.

Prompt recognition is essential to initiate the correct time-dependent treatment algorithm and prevent permanent neuronal injury.

Determine the first-line (Phase 1) abortive therapy.

Intravenous lorazepam is the initial drug of choice.

Benzodiazepines enhance GABA-A receptor inhibition and are the most effective agents for rapidly terminating ongoing seizure activity.

Determine the second-line (Phase 2) stabilization therapy.

Intravenous fosphenytoin is administered next.

If seizures continue after adequate doses of benzodiazepines, a long-acting non-anesthetic antiepileptic drug is required to establish sustained seizure control.

Determine the third-line (Phase 3) therapy for refractory status epilepticus.

Continuous intravenous propofol infusion is the next appropriate step.

When seizures are refractory to Phase 1 and 2 agents, continuous anesthetic infusions are necessary to suppress cortical activity, often requiring intubation for airway protection.

Determine the final escalation step for super-refractory status epilepticus.

Continuous intravenous pentobarbital infusion is the last resort.

Pentobarbital induces profound burst suppression and is reserved for cases that fail to respond to other anesthetic infusions due to its significant risk of hemodynamic instability and immunosuppression.

Key Concept

The step-wise pharmacologic management of status epilepticus progresses sequentially through initial benzodiazepines, long-acting non-anesthetic antiepileptic drugs, continuous anesthetic infusions, and finally barbiturate coma for super-refractory cases.

Estimated Time:1m 30s

Question 549Question →

An internal medicine physician is called to the bedside of a 24-year-old male patient who is receiving care in the critical care unit for diabetic ketoacidosis. The patient was admitted 14 hours prior and has been treated with continuous intravenous fluids, a regular insulin infusion, and an electrolyte protocol. The nursing staff reports that his vital signs are stable, and he is now awake, conversational, and asking for a meal.

Recent laboratory studies demonstrate:

Laboratory Test	Result
Sodium	140 mEq/L
Potassium	4.4 mEq/L
Chloride	108 mEq/L
Bicarbonate	22 mEq/L
Blood glucose	165 mg/dL

The clinical team determines the patient is ready to transition to a subcutaneous insulin regimen. Arrange the following steps for transitioning therapies and monitoring in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first verify resolution of ketoacidosis (closed anion gap and ability to eat), then administer subcutaneous insulin, maintain the intravenous insulin drip for a 1-to-2-hour overlap period, discontinue the intravenous drip, and finally implement routine point-of-care glucose monitoring.

The safe transition from intravenous to subcutaneous insulin in a patient with diabetic ketoacidosis (DKA) requires a precise sequence to prevent rebound ketoacidosis. First, DKA resolution must be confirmed by documenting a closed anion gap (12 mEq/L or less), blood glucose < 200 mg/dL, and the patient's ability to tolerate oral intake. Once confirmed, subcutaneous insulin must be administered. Because subcutaneous insulin requires 1 to 2 hours to reach systemic therapeutic levels, the intravenous insulin infusion must be maintained during this overlap window. Discontinuing the intravenous insulin prematurely creates a gap in insulin coverage, which leads to rapid lipolysis, ketogenesis, and relapse of DKA. After the 1-to-2-hour overlap, the intravenous drip is stopped, and routine point-of-care glucose monitoring begins to evaluate the efficacy of the new subcutaneous regimen.

Step-by-Step Solution

Assess the patient's clinical status and calculate the anion gap from the provided laboratory results.

The anion gap is 10 mEq/L (140 - [108 + 22]), and the patient is asking for a meal. Both criteria for diabetic ketoacidosis resolution are met.

Transitioning to subcutaneous insulin requires full resolution of ketoacidosis to prevent an immediate relapse.

Initiate the subcutaneous insulin regimen while the intravenous infusion continues.

Subcutaneous basal and prandial insulin are administered as the second step.

Subcutaneous insulin has a delayed onset of action and requires time to reach therapeutic serum levels.

Continue the intravenous insulin infusion for a mandatory overlap period.

The intravenous insulin is maintained for 1 to 2 hours after the subcutaneous injection.

This overlap provides continuous insulin coverage while the subcutaneous depot is absorbed, preventing rebound ketogenesis.

Stop the intravenous insulin infusion and establish ongoing surveillance.

The intravenous drip is discontinued, and point-of-care glucose testing is ordered.

Once the subcutaneous insulin is active, the intravenous route is no longer needed, and routine monitoring is required to adjust future doses.

Key Concept

Transitioning from intravenous to subcutaneous insulin in diabetic ketoacidosis requires confirming anion gap closure and maintaining a 1-to-2-hour overlap of intravenous insulin after administering the subcutaneous dose to prevent rebound acidosis.

Question 550Question →

A 64-year-old man is currently receiving mechanical ventilation in the intensive care unit following a severe traumatic brain injury. On hospital day 5, he develops a new fever of 39.2°C (102.6°F), an increased requirement for fraction of inspired oxygen (FiO2), and thick, purulent endotracheal secretions. A portable chest radiograph reveals a new left lower lobe consolidation. The patient is hemodynamically stable but exhibits signs of systemic inflammation.

Arrange the following steps in the most appropriate chronological sequence for the diagnostic workup, therapeutic management, and subsequent monitoring of this patient's suspected ventilator-associated pneumonia (VAP).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain respiratory cultures, immediately follow with empiric broad-spectrum antibiotics, clinically reassess at 48 to 72 hours alongside culture results, de-escalate to targeted therapy based on those results, and continuously monitor the patient to complete a 7-day treatment course.

The management of suspected ventilator-associated pneumonia (VAP) follows a strict sequence emphasizing both timely intervention and appropriate monitoring. First, a lower respiratory tract sample must be obtained before any new antibiotics are given; early administration can rapidly sterilize cultures and obscure the diagnosis. Second, empiric therapy targeting typical nosocomial pathogens (such as MRSA and Pseudomonas aeruginosa) must be started immediately to prevent clinical deterioration. Third, a formal clinical reassessment is required at 48 to 72 hours when final microbiologic data become available. Fourth, based on these results, the broad-spectrum regimen should be de-escalated to a targeted agent to minimize resistance. Finally, the patient's response to this targeted therapy is monitored daily to ensure clinical stability, with the goal of completing a standard 7-day treatment course.

Step-by-Step Solution

Establish a microbiologic diagnosis prior to treatment.

Lower respiratory tract cultures and a Gram stain are obtained.

To accurately identify the pathogen and its susceptibilities, which is crucial for guiding later targeted therapy. Antibiotics given beforehand can sterilize the sample.

Provide immediate empiric broad-spectrum treatment.

Intravenous antibiotics covering MRSA and Pseudomonas aeruginosa are initiated.

To ensure timely coverage of severe hospital-acquired pathogens while awaiting definitive culture results, minimizing morbidity.

Perform a scheduled clinical and microbiologic reassessment.

The patient's clinical response and final culture results are evaluated at 48 to 72 hours.

To determine the effectiveness of the initial regimen and gather the necessary data for antimicrobial stewardship interventions.

Implement antimicrobial stewardship by narrowing therapy.

The antibiotic regimen is de-escalated to narrow-spectrum agents.

To minimize patient toxicity, reduce healthcare costs, and prevent the emergence of multidrug-resistant organisms and Clostridioides difficile infection.

Complete the treatment course and monitor for infection resolution.

The patient's clinical status is monitored daily until a standard 7-day course is completed.

To confirm that the infection has cleared while adhering to guideline-recommended shorter durations for VAP to minimize harm.

Key Concept

The optimal sequence for evaluating, treating, and monitoring ventilator-associated pneumonia incorporates prompt pre-antibiotic culturing, immediate broad-spectrum empiric therapy, and subsequent culture-guided de-escalation with a limited 7-day duration.

Question 551Question →

During a routine health maintenance examination, a physician evaluates a patient with poorly controlled type 2 diabetes mellitus and new-onset eruptive xanthomas on the extensor surfaces. Fasting laboratory results reveal a serum triglyceride concentration of $1,340 \text{ mg/dL}$ . The patient is currently managed with metformin monotherapy and lacks any history of atherosclerotic cardiovascular disease.

Please arrange the following clinical actions in the correct chronological sequence for the management and monitoring of this patient's condition over time.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first prescribe fenofibrate to prevent pancreatitis, then recheck the lipid panel in 4 to 8 weeks, subsequently initiate statin therapy once triglycerides are

<500 \text{ mg/dL}

, and finally monitor for adverse effects of the combination therapy.

The management of severe hypertriglyceridemia (

\ge 1,000 \text{ mg/dL}

) follows a strict sequence driven by competing clinical risks. The immediate danger is acute pancreatitis, dictating that fibrate therapy (e.g., fenofibrate) must be initiated first. Once the patient begins the fibrate, the physician must evaluate the therapeutic response by rechecking a fasting lipid panel in 4 to 8 weeks. When the triglyceride level safely drops below

500 \text{ mg/dL}

, the acute threat of pancreatitis is resolved. At this point, the patient's long-term risk of atherosclerotic cardiovascular disease (ASCVD) takes precedence. Because this patient has diabetes, a statin is strongly indicated for primary prevention. Finally, because the patient is now on combination therapy (statin plus fibrate), they are at an elevated risk for myopathy and hepatic toxicity, necessitating ongoing clinical and laboratory monitoring.

Step-by-Step Solution

Identify the immediate clinical threat.

The triglyceride level of

1,340 \text{ mg/dL}

places the patient at high imminent risk for acute pancreatitis.

Triglyceride levels above

500-1,000 \text{ mg/dL}

require immediate fibrate therapy rather than statins to prevent pancreatic inflammation.

Evaluate the initial treatment response.

A follow-up lipid panel is ordered 4 to 8 weeks after starting fenofibrate.

Monitoring ensures the medication is effectively lowering triglycerides below the critical

500 \text{ mg/dL}

threshold, establishing safety.

Address long-term cardiovascular risk.

Statin therapy is initiated.

Once triglycerides are

<500 \text{ mg/dL}

, the primary goal shifts to atherosclerotic cardiovascular disease (ASCVD) prevention, indicated for diabetic patients.

Monitor for adverse effects of combination therapy.

The patient is assessed for myopathy and transaminitis.

The combination of a fibrate and a statin increases the risk of muscle toxicity and liver injury, requiring careful post-initiation surveillance.

Key Concept

In patients with severe hypertriglyceridemia (

\ge 500-1,000 \text{ mg/dL}

), the initial focus is preventing acute pancreatitis with fibrates; once triglycerides are successfully monitored and confirmed to be

<500 \text{ mg/dL}

, the focus shifts to ASCVD risk reduction with statins, followed by clinical evaluation for combined toxicity.

Question 552Question →

A 34-year-old male patient presents for an initial primary care evaluation to establish care. He reports feeling entirely well and has no specific health concerns. He denies headaches, palpitations, diaphoresis, or muscle weakness. He takes no medications and does not use tobacco or illicit drugs. Family history is notable for type 2 diabetes in his father, but no early-onset cardiovascular disease. His blood pressure is 166/104 mmHg. A repeat measurement after 15 minutes of rest is 164/102 mmHg. Physical examination reveals a body mass index (BMI) of 23.5 kg/m $^2$ . The abdomen is soft without bruits, and there are no abnormal skin findings or fat redistribution.

Laboratory studies are obtained with the following results:

Laboratory Parameter	Result	Reference Range
Sodium	143 mEq/L	136-145 mEq/L
Potassium	3.1 mEq/L	3.5-5.0 mEq/L
Chloride	102 mEq/L	98-106 mEq/L
Bicarbonate	29 mEq/L	22-28 mEq/L
Blood urea nitrogen	14 mg/dL	8-20 mg/dL
Creatinine	0.8 mg/dL	0.7-1.3 mg/dL

Arrange the following differential diagnoses in order from HIGHEST pre-test probability to LOWEST pre-test probability based on this patient's clinical presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from highest to lowest pre-test probability is: Primary hyperaldosteronism, Renovascular hypertension, Cushing syndrome, and Pheochromocytoma.

Evaluating secondary hypertension requires integrating laboratory findings with patient demographics. The patient has unprovoked hypokalemia and mild metabolic alkalosis. Primary hyperaldosteronism is the textbook cause of this triad (hypertension, hypokalemia, alkalosis) in an otherwise healthy young adult, making it the most likely diagnosis. Renovascular disease is a strong secondary consideration as it mimics this physiology via the renin-angiotensin-aldosterone system, but it is epidemiologically discordant for a young male without an abdominal bruit. Cushing syndrome is ranked lower due to a complete lack of physical exam findings (no central obesity or striae), and pheochromocytoma is ranked lowest as it does not physiologically explain the electrolyte derangements and lacks the classic paroxysmal symptoms.

Step-by-Step Solution

Analyze the patient's objective data and demographic profile.

The patient is a young, healthy male with severe asymptomatic hypertension, spontaneous hypokalemia (3.1 mEq/L), and mild metabolic alkalosis (Bicarbonate 29 mEq/L).

Identifying the core triad of hypertension, hypokalemia, and alkalosis narrows the differential to conditions affecting the mineralocorticoid axis.

Prioritize diagnoses that directly explain the electrolyte derangements.

Primary hyperaldosteronism perfectly matches the unprovoked hypokalemia and alkalosis. Renovascular disease can mimic this via secondary hyperaldosteronism.

Direct mineralocorticoid excess drives renal potassium wasting and hydrogen ion excretion.

Use epidemiological data and negative physical exam findings to further stratify the differential.

Renovascular disease is lowered in probability due to the patient's demographics (young male, no bruit). Cushing syndrome is lowered due to the absence of physical stigmata. Pheochromocytoma is ranked lowest as it does not cause hypokalemia and the patient lacks paroxysmal symptoms.

Pre-test probability depends not just on physiological possibility, but on population demographics and the presence or absence of classic clinical hallmarks.

Key Concept

Prioritizing the differential diagnosis for secondary hypertension based on metabolic derangements (hypokalemia, alkalosis) and demographic risk factors.

Estimated Time:1m 30s

Question 553Question →

A 68-year-old man is hospitalized for a severe exacerbation of chronic obstructive pulmonary disease and newly diagnosed heart failure with preserved ejection fraction. He has stabilized after 4 days of intravenous diuresis and systemic corticosteroids. The medical team is preparing for his transition out of the acute care hospital. He lives with his daughter, who works during the day. He requires new supplemental oxygen and close monitoring of his fluid status. To minimize the risk of readmission and ensure a safe transition of care, arrange the following discharge planning steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a high-risk patient begins with determining the appropriate disposition setting, followed by medication reconciliation, arranging logistical needs, educating the patient and family, and finally transmitting the transition of care documents to receiving providers.

Safe discharge planning follows a logical progression. The healthcare team must first know where the patient is going (disposition). Next, they must finalize what the medical plan is (medication reconciliation). Then, they coordinate the resources needed to support that plan (appointments and durable medical equipment). Only when the plan is fully constructed can the patient and family be properly educated on it. Finally, the completed plan is formally sent to the next providers in the continuum of care to complete the handoff.

Step-by-Step Solution

Determine the optimal post-acute care setting.

The multidisciplinary team assesses the patient's functional status and social support to decide between home care, a rehabilitation center, or another setting.

This establishes the foundation of the discharge plan and dictates all subsequent clinical and logistical needs.

Reconcile all medications.

The physician reviews and finalizes the patient's pre-admission, inpatient, and planned discharge medications.

An accurate, updated medication list is required before any logistical planning or patient education can occur.

Coordinate logistics, appointments, and equipment.

Early follow-up appointments are scheduled, and supplemental oxygen delivery is arranged.

These logistical elements must be secured based on the finalized medical plan before educating the patient on their post-discharge routine.

Educate the patient and caregiver.

The nursing staff uses teach-back methods to review the finalized medications, appointments, and clinical warning signs.

Patients cannot be safely educated until the entire medical and logistical plan is completely finalized to avoid conveying conflicting information.

Transmit handoff documents.

The final discharge summary is sent to the primary care physician and outpatient clinical teams.

The receiving providers need the comprehensive, finalized transition plan to assume care safely and prevent readmissions.

Key Concept

Safe transitions of care for high-risk patients require a structured, chronological approach starting with disposition determination and culminating in the handoff of a finalized care plan to outpatient providers.

Question 554Question →

A 52-year-old man is brought to the emergency department by paramedics after being found unresponsive at home. His wife reports that he had been vomiting large amounts of bright red blood for the past hour. The patient has a history of alcohol use disorder and cirrhosis. On arrival, he is obtunded, making gurgling respiratory sounds, and has blood pooling in his oropharynx. Vital signs are temperature 36.5°C (97.7°F), blood pressure 70/40 mmHg, pulse 142/min, and respiratory rate 28/min. Arrange the following management steps in the most appropriate sequential order of priority for this patient's initial stabilization.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence prioritizes the ABCs of resuscitation: secure the airway, establish vascular access, resuscitate with blood products, administer etiology-specific medical therapy, and finally perform definitive therapeutic endoscopy.

In any critically ill patient, stabilization must sequentially follow the ABCs (Airway, Breathing, Circulation). This patient requires immediate definitive airway management prior to addressing his hemorrhagic shock or attempting to intervene on the underlying bleeding source.

Step-by-Step Solution

Assess the airway and identify the need for definitive protection.

The patient is obtunded with blood in the oropharynx, requiring immediate endotracheal intubation.

Failure to protect the airway in this state will lead to massive aspiration, hypoxia, and death before any other interventions can be effective.

Assess circulation and initiate hemodynamic support.

Two large-bore IVs are placed, followed by immediate transfusion of uncrossmatched blood.

The patient is in profound hemorrhagic shock requiring rapid restoration of intravascular volume and oxygen-carrying capacity.

Initiate medical management for the specific etiology.

Octreotide and antibiotics are administered.

The history strongly suggests variceal hemorrhage. Octreotide decreases portal pressures, and antibiotics decrease mortality in cirrhotic patients with GI bleeding.

Plan definitive procedural intervention.

Gastroenterology is consulted for urgent esophagogastroduodenoscopy.

Once the patient is stabilized, endoscopy is required to identify and definitively treat the bleeding source.

Key Concept

In critically ill patients with severe gastrointestinal hemorrhage and altered mental status, airway protection must precede all other resuscitation and diagnostic efforts.

Estimated Time:1m 30s

Question 555Question →

A 75-year-old man is preparing for discharge to a skilled nursing facility (SNF) after a 12-day hospitalization for decompensated heart failure and acute kidney injury. The attending physician is initiating the transition of care. To maximize patient safety and prevent transition-related adverse events, arrange the following steps of the discharge and handoff process in the most appropriate chronological sequence according to best-practice transition of care protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Confirm clinical stability, 2) Perform medication reconciliation, 3) Generate the written discharge summary, 4) Transmit the documentation and orders, 5) Conduct a synchronous verbal handoff.

A safe transition of care to a skilled nursing facility follows a structured, evidence-based sequence. First, the patient's readiness for discharge and the correct destination must be established. Second, a thorough medication reconciliation must be completed to prevent adverse drug events, which are the most common post-discharge complication. Third, this reconciled list is incorporated into a comprehensive written discharge summary that outlines the hospital course and pending actionable items. Fourth, this written information must be successfully transmitted to the receiving facility so the accepting team has the necessary medical orders to provide immediate care upon arrival. Finally, a synchronous (verbal or telephone) handoff with the accepting clinician closes the communication loop, ensuring the receiving team understands the contingency plans and has an opportunity to clarify any ambiguities.

Step-by-Step Solution

Assess the patient's clinical status and confirm the discharge destination.

The patient is deemed medically stable for transfer to a skilled nursing facility.

Establishing readiness for discharge and the correct level of care is the prerequisite for all subsequent planning.

Complete a full medication reconciliation.

A unified, accurate list of post-discharge medications is established.

Medication discrepancies are the leading cause of adverse events post-discharge; resolving them is required before transition documents can be accurately written.

Write the formal discharge summary.

A standardized document containing the hospital course, reconciled medications, and pending items is generated.

The receiving facility needs a comprehensive, accurate clinical narrative to understand the patient's recent acute illness.

Send the documentation to the receiving SNF.

The SNF receives the medical orders and summary before or exactly when the patient arrives.

Accepting nurses and physicians must have actionable orders immediately upon the patient's arrival to avoid delays in care.

Perform a synchronous verbal handoff.

Closed-loop communication is achieved with the receiving provider.

Verbal handoffs allow the sending physician to highlight critical vulnerabilities, discuss 'if-then' contingency plans, and permit the receiving physician to ask clarifying questions.

Key Concept

Standardized, structured discharge protocols are essential for safe transitions of care, requiring sequential completion of medication reconciliation, written documentation, data transmission, and synchronous verbal handoffs.

Estimated Time:1m 30s

Question 556Question →

A 35-year-old woman presents to the clinic to discuss her risk for breast cancer. Her mother and maternal aunt were both diagnosed with breast cancer in their early 40s. The patient's mother recently underwent genetic testing and was told she has a pathogenic BRCA1 mutation. The patient is currently asymptomatic but is requesting genetic testing for herself to understand her risk. Arrange the following steps in the most appropriate standard sequence for the clinical genetic evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The most appropriate chronological order is: 1) Verify the specific familial mutation, 2) Conduct pre-test genetic counseling, 3) Obtain informed consent and collect the specimen, 4) Provide post-test counseling, and 5) Develop a personalized cancer screening and management plan.

In the context of predictive genetic testing for a known familial mutation (such as BRCA1), the established standard of care follows a specific sequence to ensure clinical accuracy and ethical practice. First, the exact pathogenic variant must be verified from the affected relative's official report to ensure the correct targeted molecular test is ordered. Second, comprehensive pre-test genetic counseling is mandatory to ensure the patient understands the psychosocial, medical, and financial implications. Third, after informed consent is obtained, a biological sample is drawn for the targeted molecular analysis. Fourth, post-test counseling is provided to interpret the results accurately for the patient. Finally, these molecular results are used to formulate a personalized, long-term clinical management and surveillance plan.

Step-by-Step Solution

Verify the familial mutation

The exact molecular target is identified

Ensures the correct targeted test is ordered instead of an unnecessary full sequencing panel.

Pre-test counseling

The patient is fully informed of the risks and benefits

Required for ethical genetic testing and informed decision-making prior to any procedure.

Consent and sample collection

The DNA sample is sent for targeted analysis

Initiates the actual molecular diagnostic process after the patient is fully informed.

Post-test counseling

The patient understands their genetic status

Critical for accurately interpreting complex molecular results for the patient.

Clinical management

A long-term surveillance plan is established

Applies the genetic findings to prevent or achieve early detection of future disease.

Key Concept

Clinical workflow for predictive genetic testing of familial mutations

Question 557Question →

A 3-week-old male infant is evaluated in the pediatric genetics clinic for profound central hypotonia, a poor suck reflex requiring nasogastric tube feeding, and cryptorchidism. The clinical team strongly suspects Prader-Willi syndrome. Arrange the following diagnostic modalities in the correct sequential order recommended to first confirm the clinical diagnosis and subsequently determine the exact underlying molecular etiology, proceeding from the initial confirmatory test to the evaluation for the rarest genetic mechanism.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence begins with DNA methylation analysis to confirm the diagnosis, followed by chromosomal microarray to evaluate for a microdeletion, short tandem repeat analysis to evaluate for uniparental disomy, and finally sequencing of the imprinting center to identify rare defects.

The diagnostic algorithm for Prader-Willi syndrome is strictly tiered based on test sensitivity and the epidemiological frequency of the underlying molecular mechanisms. DNA methylation is the most sensitive initial test (>99%). Once confirmed, determining the exact molecular mechanism is required for genetic counseling. The mechanisms are evaluated in order of prevalence: CMA for paternal deletion (~70%), STR analysis for maternal UPD (~25%), and finally sequencing for imprinting center defects (~1-3%).

Step-by-Step Solution

Perform DNA methylation analysis.

Confirms the diagnosis of Prader-Willi syndrome.

It detects the lack of a functional paternal allele in over 99% of cases, making it the most sensitive initial screening test, though it does not identify the specific underlying mechanism.

Perform chromosomal microarray analysis (CMA).

Evaluates for a 15q11-q13 microdeletion.

Paternal microdeletion is the most common cause (70%). CMA is the most efficient next step to visualize this deletion once the disease is confirmed.

Perform short tandem repeat (STR) polymorphism analysis.

Evaluates for maternal uniparental disomy (UPD).

If CMA is negative, UPD is the next most likely cause (25%). STR compares the infant's alleles to both parents to confirm if both copies of chromosome 15 are maternal in origin.

Perform Sanger sequencing of the imprinting center.

Identifies imprinting center defects.

If STR shows normal biparental inheritance, an imprinting center defect (1-3%) is the only remaining cause. This step is critical because these defects can carry up to a 50% recurrence risk for future pregnancies.

Key Concept

Stepwise molecular diagnostic algorithm for Prader-Willi syndrome

Estimated Time:1m 30s

Question 558Question →

A 45-year-old woman undergoes a hemicolectomy for a newly diagnosed right-sided colon adenocarcinoma. Her family history is significant for a mother who had endometrial cancer at age 49. The physician suspects Lynch syndrome (hereditary nonpolyposis colorectal cancer) and initiates a stepwise molecular and genetic diagnostic workup. Assuming each diagnostic test yields findings that require proceeding to the next sequential step, arrange the following management actions in the correct chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: tumor IHC for MMR proteins, followed by tumor BRAF/methylation testing, then patient germline sequencing, and finally cascade testing of relatives.

The correct sequence reflects the established, cost-effective diagnostic algorithm for Lynch syndrome. It begins with evaluating the tumor phenotype (IHC), progresses to ruling out common somatic causes of MMR deficiency (BRAF V600E/methylation), moves to definitively diagnosing the index patient via germline sequencing, and concludes by utilizing that confirmed diagnosis to guide cascade testing for at-risk family members.

Step-by-Step Solution

Determine the optimal initial screening test for a patient with suspected Lynch syndrome.

Immunohistochemical (IHC) staining of the tumor tissue for mismatch repair proteins.

Universal screening of colorectal tumors using IHC (or microsatellite instability testing) is the standard first step to identify tumors with mismatch repair deficiency.

Determine the next step if the screening test suggests mismatch repair deficiency (e.g., loss of MLH1).

Testing the tumor for a BRAF V600E mutation and MLH1 promoter hypermethylation.

Approximately 15% of sporadic colorectal cancers show MLH1 loss due to somatic promoter hypermethylation, often alongside a BRAF V600E mutation. This step rules out sporadic disease before proceeding to expensive germline testing.

Identify the confirmatory test for the patient if tumor testing is consistent with an inherited etiology.

Germline sequencing of the mismatch repair genes from a peripheral blood sample.

Lynch syndrome is defined by a hereditary, germline mutation. A definitive diagnosis requires confirming this mutation in the index patient's DNA.

Determine the management of the patient's family members once a diagnosis is confirmed.

Offer targeted (site-specific) genetic testing to first-degree relatives.

Cascade testing of relatives is only indicated after the specific pathogenic variant responsible for the syndrome is identified in the affected index patient.

Key Concept

The diagnostic algorithm for Lynch syndrome follows a stepwise progression: phenotypic tumor screening, somatic mutation testing to rule out sporadic disease, definitive germline sequencing in the index patient, and subsequent cascade testing for relatives.

Estimated Time:1m 30s

Question 559Question →

A 55-year-old man experiences a myocardial infarction, resulting in abrupt cessation of blood flow to a portion of the left ventricle. This ischemic event triggers a predictable sequence of subcellular changes leading to reversible cellular injury. Arrange the following pathophysiological events of ischemic cellular injury in the correct chronological order, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with decreased mitochondrial oxidative phosphorylation, followed by depletion of intracellular ATP stores, failure of the plasma membrane Na+/K+ ATPase pump, intracellular accumulation of sodium and water, and finally cellular and endoplasmic reticulum swelling.

Ischemic injury begins with hypoxia, which directly halts mitochondrial oxidative phosphorylation. This immediately depletes cellular ATP. Without ATP, energy-dependent processes such as the Na+/K+ ATPase pump fail. The loss of this pump causes sodium to accumulate intracellularly, which draws in water osmotically, ultimately leading to cellular and organelle swelling (hydropic change).

Step-by-Step Solution

Identify the primary insult of ischemia at the cellular level.

Decreased oxygen halts mitochondrial oxidative phosphorylation.

Oxygen is required as the final electron acceptor in the electron transport chain.

Determine the immediate biochemical consequence of halting oxidative phosphorylation.

Depletion of intracellular ATP stores.

The cell loses its primary source of energy production, and anaerobic glycolysis cannot fully compensate.

Identify the effect of ATP depletion on membrane transport.

Failure of the plasma membrane Na+/K+ ATPase pump.

This pump relies heavily on ATP to transport ions against their concentration gradients.

Assess the ionic shifts caused by pump failure.

Intracellular accumulation of sodium and water.

Sodium normally extruded by the pump remains inside the cell, pulling water with it via osmosis.

Determine the morphological result of this fluid influx.

Cellular and endoplasmic reticulum swelling.

The excess water physically expands the cell and its organelles, representing the classic hallmark of reversible cell injury.

Key Concept

Sequence of biochemical events in reversible ischemic cellular injury

Question 560Question →

A 52-year-old male presents to the transplant nephrology clinic for evaluation of a low-grade fever and a significant decrease in his daily urine output. He received a living-donor kidney transplant one month ago. His vital signs are stable, but physical examination reveals mild tenderness over the allograft site in the right lower quadrant. Recent laboratory tests show an acute elevation in his serum creatinine from a baseline of 1.3 mg/dL to 2.9 mg/dL. Arrange the following clinical steps in the optimal sequence to diagnose and manage his suspected acute cellular rejection.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first perform a Doppler ultrasound, followed by a renal allograft biopsy, then initiate high-dose intravenous methylprednisolone, and finally administer anti-thymocyte globulin if the rejection is steroid-resistant.

The standard sequence for evaluating and managing acute renal allograft dysfunction begins with non-invasive imaging. A Doppler ultrasound rules out structural, vascular, or obstructive complications. Once these are ruled out, a percutaneous biopsy is performed to confirm the diagnosis of acute cellular rejection and rule out other pathologies. The first-line medical intervention is high-dose intravenous corticosteroids. If the rejection is severe or does not respond to corticosteroids (steroid-resistant), second-line therapy with lymphocyte-depleting antibodies is indicated.

Step-by-Step Solution

Evaluate the initial approach to acute renal allograft dysfunction.

Doppler ultrasound must be performed first.

It rapidly and noninvasively rules out reversible mechanical or surgical causes like obstruction, urine leak, or thrombosis before invasive procedures are considered.

Determine the next diagnostic requirement.

A percutaneous renal allograft biopsy is needed.

It provides the definitive histologic diagnosis required to direct specific immunosuppressive therapy and exclude polyomavirus nephropathy or calcineurin inhibitor toxicity.

Order the pharmacologic interventions.

High-dose steroids followed by anti-thymocyte globulin if needed.

Steroids are the standard first-line therapy, whereas potent lymphocyte-depleting agents are reserved for refractory or severe cases due to their side effect profile.

Key Concept

Management of acute renal allograft rejection

PreviousPage 28 / 39Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept